https://scholars.lib.ntu.edu.tw/handle/123456789/566503
標題: | Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines | 作者: | Lin S.-C. Huang M.-H. Tsou P.-C. LI-MIN HUANG Chong P. Wu S.-C. |
公開日期: | 2011 | 卷: | 6 | 期: | 5 | 起(迄)頁: | e20052 | 來源出版物: | PLoS ONE | 摘要: | Background: The highly pathogenic avian influenza (HPAI) H5N1 virus continues to cause disease in poultry and humans. The hemagglutinin (HA) envelope protein is the primary target for subunit vaccine development. Methodology/Principal Findings: We used baculovirus-insect cell expression to obtain trimeric recombinant HA (rHA) proteins from two HPAI H5N1 viruses. We investigated trimeric rHA protein immunogenicity in mice via immunizations, and found that the highest levels of neutralizing antibodies resulted from coupling with a PELC/CpG adjuvant. We also found that the combined use of trimeric rHA proteins with (a) an inactivated H5N1 vaccine virus, or (b) a recombinant adenovirus encoding full-length HA sequences for prime-boost immunization, further improved antibody responses against homologous and heterologous H5N1 virus strains. Data from cross-clade prime-boost immunization regimens indicate that sequential immunization with different clade HA antigens increased antibody responses in terms of total IgG level and neutralizing antibody titers. Conclusion/Significance: Our findings suggest that the use of trimeric rHA in prime-boost vaccine regimens represents an alternative strategy for recombinant H5N1 vaccine development. ? 2011 Lin et al. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-79957796724&doi=10.1371%2fjournal.pone.0020052&partnerID=40&md5=3b30a8df62ec1c1d981c820850f27e77 https://scholars.lib.ntu.edu.tw/handle/123456789/566503 |
ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0020052 | SDG/關鍵字: | adenovirus vector; CpG oligodeoxynucleotide; immunoglobulin G; immunoglobulin G1; immunoglobulin G2a; neutralizing antibody; recombinant Influenza virus hemagglutinin; recombinant protein; sorbitan trioleate; squalene; unclassified drug; influenza vaccine; Influenza virus hemagglutinin; Adenovirus; animal experiment; antibody response; antibody titer; article; baculovirus expression system; cladistics; controlled study; female; immunization; immunogenicity; influenza A (H5N1); Influenza virus A H5N1; mouse; nonhuman; nucleotide sequence; treatment outcome; virus inactivation; virus recombinant; virus strain; animal; Bagg albino mouse; enzyme linked immunosorbent assay; immunology; Adenoviridae; Aves; Avian influenza virus; Hexapoda; Mus; Animals; Enzyme-Linked Immunosorbent Assay; Female; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Mice; Mice, Inbred BALB C |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。